DENVER, Colo., Dec 1, 2023 (www.247marketnews.com)- 24/7 Market News reported that NexImmune (NASDAQ:NEXI) shares were blasting off, in this morning’s premarket trading. We commented that it hasn’t published news since before November, but somehow today’s volume would surely set a 52-week high, so it was set to take out multiple resistance levels along the way.
That fishy stench grew stronger when Nasdaq issued NexImmune a T-12 Halt.
Neximmune is now trading again after filing a “Failure to Satisfy Listing Rule – Form 8-K” this afternoon, confirming that NexImmune received notice from Nasdaq’s Listing Qualifications Department, on November 30, 2023, notifying Neximmune that based on Nasdaq’s review of Neximmune and pursuant to Nasdaq Listing Rule 5101, Nasdaq believes that Neximmune is a “public shell,” and that the continued listing of its securities is no longer warranted.
Neximmune must now satisfactorily appeal Nasdaq’s determination and stated that it “intends to timely request a hearing”, but there is “no assurance that the Company will ultimately be able to demonstrate compliance with all applicable listing criteria.”
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.